Kura Oncology, Inc Hiring for Director/Sr Director, Brand Strategy & HCP Marketing at San Diego, CA, United States Full Time

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines?

At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of.

At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics.

As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality.

To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude.

The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.

ESSENTIAL JOB FUNCTIONS :

• The Director / Senior Director, Brand Strategy & HCP Marketing will be responsible for building and leading a fully integrated brand strategy), development and implementation of marketing plans for Kura Oncology’s lead pipeline asset
• This position will be integral to the global commercial strategy for Kura Oncology’s lead pipeline asset, as well as shaping, preparing and implementing the US launch plan for our first commercialization and launch.
• Define and lead development of the lead pipeline asset strategy incorporating multiple indications as part of life cycle management planning
• Partner with cross-functional colleagues to assess gaps and strategic needs to ensure market leadership of our lead pipleline asset franchise
• Partner with Insights & Analytics team to define success metrics and analyze performance on an ongoing basis
• Support P&L for lead asset; assess investment priorities and synergies to maximize operating efficiencies in collaboration with cross-functional partners
• Assess value of marketing programs based on anticipated ROI / value / impact and formulate recommendations for future plans based on key learnings
• Lead the vision for new indication preparation, develop the plan for market entry and ensure strategically aligned initiatives to drive the brand strategy and imperatives
• Overall, lead the marketing team’s efforts to develop and communicate field promotional strategy and assets and monitor field performance against KPIs, building strong, enduring relationships with the cross functional field and leadership teams to ensure excellence in execution
• Responsible for managing multiple program budgets, timelines, processes, and procedures
• Manage partner agency relationships, workflow, and related expense budgets
• Support, lead and develop key members of the marketing team to achieve their full potential, to ensure talent growth and expertise
• Collaborate with other functional areas and lead the review process to ensure legal / regulatory compliance and medical accuracy of all marketing materials

JOB SPECIFICATIONS :

• BS / BA degree in business or related discipline with 8+ years’ experience in Oncology / Hematology pharmaceutical marketing or 6+ years with MBA
• Multiple US pharmaceutical product and indication launch experiences in Oncology / Hematology
• Experience in one or more of the following functions in addition to marketing : market access, sales, market research / analytics, strategic planning
• Ability to manage multifaceted projects and collaborate in a highly matrixed environment
• Demonstrated ability to lead cross-functional teams
• Deep understanding within the US of the diagnostic and payer landscapes in both public and private segments
• Demonstrated ability to have the managerial courage to make and stand by difficult decisions
• Exceptional organization and multitasking skills
• Ability to accommodate shifting priorities, demands and timelines
• Experience building and leading teams and self in high growth, fast paced environments.
• Highly skilled in influencing cross-functional teams, including interfacing with key internal and external stakeholders and with scientific and commercial functions.
• Ability to garner the trust and confidence of the organization from your direct team to the senior leadership team.
• Exceptional communication skills : equally effective in front of field teams as you are in front of the senior leadership and Board of Directors

The base range for a Director is $205,342 – $235,943 per year. Senior Director base range is $254,625 – $284,344. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training.

Kura’s compensation package also includes generous benefits, equity, and participation in an annual target bonus.

Kura’s Values that are used for candidate selection and performance assessments :

• We work as one for patients
• We are goal-focused and deliver with excellence
• We are science-driven courageous innovators
• We strive to bring out the best in each other and ourselves

The Kura Package

• Career advancement / development opportunities
• Competitive comp package
• Bonus
• 401K + Employer contributions
• Generous stock options
• ESPP Plan
• 20 days of PTO to start
• 18 Holidays (Including Summer & Winter Break)
• Generous Benefits Package with a variety of plans available with a substantial employer match
• Paid Paternity / Maternity Leave
• In-Office Catered lunches
• Home Office Setup
• Lifestyle Spending Stipend
• Commuter Stipend (Boston Office)
• Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more!

Kura Oncology is a clinical-stage biopharmaceutical company discovering and developing personalized therapeutics for the treatment of solid tumors and blood cancers.

The company’s diverse pipeline consists of small molecules that target cancer signaling pathways where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment.

Kura Oncology’s approach to drug development is focused on rapidly translating novel science into life-saving medicines.

Our goal is to help patients with cancer lead better, longer lives. Kura Oncology has offices in San Diego, California, and Boston, Massachusetts.

Kura’s pipeline consists of three investigational drug candidates : ziftomenib, tipifarnib and KO-2806. Ziftomenib is a once-daily, oral drug candidate targeting the menin-KMT2A protein-protein interaction for the treatment of genetically defined AML patients with high unmet need.

Ziftomenib is currently enrolling patients in a Phase 2 registration-directed trial (KOMET-001) in NPM1-mutant relapsed or refractory AML.

Kura is preparing to initiate multiple Phase 1 trials to evaluate ziftomenib in combination with current standards of care in earlier lines of therapy and across multiple patient populations, including NPM1-mutant and KMT2A-rearranged AML.

Tipifarnib, a potent and selective FTI, is currently in a Phase 1 / 2 trial (KURRENT-HN) in combination with alpelisib for patients with PIK3CA-dependent HNSCC.

Kura intends to evaluate KO-2806, a next-generation FTI, in a Phase 1 dose-escalation trial (FIT-001) as a monotherapy and in combination with other targeted therapies in adult patients with advanced solid tumors.

For additional information, please visit Kura’s website at www.kuraoncology.com.

Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.